Search Results - "Federico Yandián"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Nefritis lúpica by Adriana Carlomagno, Gonzalo Silveira, Álvaro Danza, Ana Carina Pizzarossa, Martín Yandián, Federico Yandián, Martín Rebella

    Published in Revista médica del Uruguay (01-10-2021)
    “…Introducción: las recomendaciones actuales del tratamiento de la nefritis lúpica (NL) apuntan a dosis de glucocorticoides más bajas para lograr el control de…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Hydroxychloroquine Dose and Risk of Systemic Lupus Erythematosus Flares/Reply by Caravaca-Fontán, Fernando, Yandian, Federico, Fervenza, Fernando C, Jorge, April M, Zhang, Yuqing, Choi, Hyon K

    “…The primary objective of our study was to evaluate the efficacy of hydroxychloroquine dosing on the outcome of overall lupus flares. Our study population…”
    Get full text
    Journal Article
  9. 9

    Updated diagnostic and therapeutic management for membranous nephropathy by Caravaca-Fontán, Fernando, Yandian, Federico, Fervenza, Fernando C.

    “…Pioneering contributions in membranous nephropathy over the last decade have greatly enhanced our comprehension of its pathogenesis, diagnosis, and treatments,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Future landscape for the management of membranous nephropathy by Caravaca-Fontán, Fernando, Yandian, Federico, Fervenza, Fernando C

    Published in Clinical kidney journal (01-08-2023)
    “…Among all glomerular diseases, membranous nephropathy (MN) is perhaps the one in which major progress has been made in recent decades, in both the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Antimalarials in Lupus Nephritis: How Strong is the Evidence? by Caravaca-Fontán, Fernando, Yandian, Federico, Zand, Ladan, Sethi, Sanjeev, Fervenza, Fernando C

    Published in Kidney360 (21-10-2024)
    “…Systemic lupus erythematosus is a chronic multisystem autoimmune disease that affects the kidneys in approximately 50% of patients, with prevalence rising to…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Trasplante hepatorrenal por hiperoxaluria primaria: reporte del primer caso en Uruguay y revisión de la literatura by Dufort, Mariana, Seija, Mariana, Astesiano, Rossana, Santiago, José, Yandian, Federico, Halty, Margarita, Rebori, Anabella, Gerona, Solange, Noboa, Óscar, Nin, Marcelo

    Published in Nefrología Latinoamericana (20-12-2022)
    “…La hiperoxaluria primaria (HOP) es una enfermedad hereditaria autosómica recesiva del metabolismo del glioxalato, con sobreproducción de oxalato,…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Kidney Diseases Associated With Inflammatory Bowel Disease: Impact of Chronic Histologic Damage, Treatments, and Outcomes by Yandian, Federico, Caravaca-Fontán, Fernando, Herrera Hernandez, Loren P, Soler, Maria José, Sethi, Sanjeev, Fervenza, Fernando C

    Published in Kidney international reports (01-02-2024)
    “…Kidney disease is a well-known extraintestinal manifestation (EIM) associated with inflammatory bowel disease (IBD), with a variety of underlying etiologies…”
    Get full text
    Journal Article
  19. 19